Autoimmune Diseases Diagnostics Market to Witness Upsurge in Growth by 2030, Assesses DelveInsight

DelveInsight's Autoimmune Diseases Diagnostics Market Insights Report provides the current and forecast market analysis, individual leading Autoimmune Diseases Diagnostics Companies market shares, challenges, Autoimmune Diseases Diagnostics Market Drivers, barriers, trends, and key market Autoimmune Diseases Diagnostics Companies in the market.

To read more about the latest highlights related to the Autoimmune Diseases Diagnostics Market, get a snapshot of the key highlights entailed in the Market Report @ Autoimmune Diseases Diagnostics Tests Pipeline Product Market [https://www.delveinsight.com/sample-request/autoimmune-diseases-diagnostics-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Key Takeaways from the Autoimmune Diseases Diagnostics Market Report

* In May 2025, Novartis Pharmaceuticals conducted a study was to compare the ability of eltrombopag in combination with a short course of high-dose dexamethasone to induce sustained response off treatment in patients with newly-diagnosed ITP versus 1-3 cycles of dexamethasone monotherapy.
* The global Autoimmune Disease Diagnostics Market is estimated to grow at a CAGR of 5.53% during the forecast period from 2024 to 2030 to reach USD 6.41 billion by 2030.
* The leading Autoimmune Disease Companies such as Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, Werfen, Bio-Rad Laboratories, Exagen Inc., Grifols, S.A, Medical & Biological Laboratories Co. Ltd, RSR Limited, DiaSorin S.p.A, Laboratory Corporation of America Holdings, Abcam plc, EUROIMMUN Medizinische Labordiagnostika AG, Quest Diagnostics, Hemagen Diagnostics, Inc., AESKU Diagnostics GmbH & Co. KG, Trinity Biotech Biomerieux SA and others.

To know more about why North America is leading the market growth in the Autoimmune Diseases Diagnostics Market, get a snapshot @ Autoimmune Diseases Diagnostics Market Outlook [https://www.delveinsight.com/sample-request/autoimmune-diseases-diagnostics-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Autoimmune Disease Diagnostics Market Dynamics

As per the data published by Multiple Sclerosis International Federation in 2020, the number of people suffering from multiple sclerosis has increased from 2.3 million in 2013 to 2.8 billion in 2020, globally. Furthermore, according to statistics provided by the World Health Organization (WHO) in the year 2023, around 18 million individuals worldwide suffered from rheumatoid arthritis in 2019. According to the same source, around 70% of persons suffering from rheumatoid arthritis in 2019 were women, with 55% being over the age of 55. Thus the rising prevalence of autoimmune disorders will create a need for diagnosis of autoimmune disorders, thus resulting in the positive growth of the Autoimmune Disease Diagnostic Market.

Autoimmune Disease Diagnostics Market Segment Analysis

Autoimmune Disease Diagnostics Market by Product (Reagents & Kits and Instruments), Disease type (Localized Autoimmune Disease and Systemic Autoimmune Disease), Test (Antinuclear Antibody Test, Autoantibody Test, Complete Blood Count, Comprehensive Metabolic Panel, C-reaction Protein, Erythrocyte Sedimentation Rate, and Urinalysis), End-users (Hospitals & Clinics, Diagnostic Centers, and Others) and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

Get a sneak peek at the Autoimmune Diseases Diagnostics Tests Pipeline Product Market @ Autoimmune Diseases Diagnostics Market Dynamics Analysis [https://www.delveinsight.com/sample-request/autoimmune-diseases-diagnostics-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Autoimmune Diseases Diagnostics Companies

Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, Werfen, Bio-Rad Laboratories, Exagen Inc., Grifols, S.A, Medical & Biological Laboratories Co. Ltd, RSR Limited, DiaSorin S.p.A, Laboratory Corporation of America Holdings, Abcam plc, EUROIMMUN Medizinische Labordiagnostika AG, Quest Diagnostics, Hemagen Diagnostics, Inc., AESKU Diagnostics GmbH & Co. KG, Trinity Biotech Biomerieux SA and others.

Autoimmune Diseases Diagnostics Market Drivers

The demand for diagnosis of autoimmune diseases is primarily being boosted by the increasing number of cases of autoimmune disorders such as Rheumatoid Arthritis, Type I Diabetes, and Addison's Disease among others. Additionally, the rising awareness among people regarding early disease diagnosis and the rising technological advancement in the healthcare domain, are also contributing to the growth of the Autoimmune Diagnostics Market during the forecast period from 2024-2030.

Which MedTech key players in the Autoimmune Diseases Diagnostics Market are set to emerge as the trendsetter explore @ Autoimmune Diseases Diagnostics Companies [https://www.delveinsight.com/sample-request/autoimmune-diseases-diagnostics-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Scope of the Autoimmune Diseases Diagnostics Tests Pipeline Product Market

* Coverage- Global
* Autoimmune Diseases Diagnostics Companies- Beckman Coulter, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermofisher Scientific, Werfen, Bio-Rad Laboratories, Exagen Inc., Grifols, S.A, Medical & Biological Laboratories Co. Ltd, RSR Limited, DiaSorin S.p.A, Laboratory Corporation of America Holdings, Abcam plc, EUROIMMUN Medizinische Labordiagnostika AG, Quest Diagnostics, Hemagen Diagnostics, Inc., AESKU Diagnostics GmbH & Co. KG, Trinity Biotech Biomerieux SA and others.
* Autoimmune Diseases Diagnostics Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World

Interested in knowing the Autoimmune Diseases Diagnostics Market by 2030? Click to get a snapshot of the Autoimmune Diseases Diagnostics Market Trends [https://www.delveinsight.com/sample-request/autoimmune-diseases-diagnostics-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]

Table of Contents

1. Autoimmune Disease Diagnostic Market Report Introduction

2. Autoimmune Disease Diagnostics Market Executive Summary

3. Regulatory Analysis

4. Autoimmune Disease Diagnostics Market Key Factors Analysis

5. Autoimmune Disease Diagnostics Market Porter's Five Forces Analysis

6. Autoimmune Disease Diagnostics Market Layout

7. Autoimmune Diagnostics Market Company and Product Profiles

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=autoimmune-diseases-diagnostics-market-to-witness-upsurge-in-growth-by-2030-assesses-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/autoimmune-diseases-diagnostics-market

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.